Human CMV (HCMV) encodes multiple genes that control NK cell activation and cytotoxicity.
Some of these HCMV-encoded gene products modulate NK cell activity as ligands …

Human CMV (HCMV) interferes with NK cell functions at various levels. The HCMV
glycoprotein UL16 binds some of the ligands recognized by the NK-activating receptor …

Human cytomegalovirus (HCMV) employs a variety of strategies to modify or evade the host
immune response, and natural killer (NK) cells play a crucial role in controlling …

Human cytomegalovirus (HCMV) has evolved a multitude of molecular mechanisms to
evade the antiviral immune defense of the host. Recently, using soluble recombinant …

Infection by human CMV induces expression of the cellular MHC class I-related chain A
(MICA) and chain B (MICB) surface proteins, which function as ligands for the activating …

Both human and mouse cytomegaloviruses (CMVs) encode proteins that inhibit the
activation of NK cells by down-regulating cellular ligands for the activating NK cell receptor …

The activating receptor, NKG2D, is expressed on a variety of immune effector cells and
recognizes divergent families of major histocompatibility complex (MHC) class I–related …

The NK cell–activating receptor NKG2D interacts with three different cellular ligands, all of
which are regulated by mouse cytomegalovirus (MCMV). We set out to define the viral gene …

Human cytomegalovirus (HCMV) evades T-cell recognition by down-regulating expression
of major histocompatibility complex (MHC) class I and II molecules on the surfaces of …

Human cytomegalovirus (HCMV) is a ubiquitous pathogen that causes morbidity risk in
immunologically suppressed and immunodeficient patients including congenital infections …